Skip to main content

Advertisement

Log in

Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

According to LI-RADS, a major discriminating feature between hepatocellular carcinoma (HCC) and non-HCC malignancies is the subtype of arterial phase hyperenhancement (APHE). The aim of this study was to investigate whether APHE subtypes are consistent across multi-arterial phase (mHAP) MRI acquisitions while evaluating reader agreement. Secondarily, we investigated factors that may affect reader agreement for APHE subtype.

Methods

In this retrospective study, consecutive patients with liver cirrhosis and focal observations who underwent mHAP were included. Five radiologists reviewed MR images in 2 reading sessions. In reading session 1, individual AP series were reviewed and scored for presence of APHE and subtype. In reading session 2, readers scored observations’ major and ancillary features and LI-RADS category in the complete MRI examination. Reader agreement was calculated using Fleiss’ kappa for binary outcomes and Kendall’s coefficient of concordance for LI-RADS categories. Univariate mixed effects logistic regressions were performed to investigate factors affecting agreement.

Results

In total, 61 patients with 77 focal observations were analyzed. Of observations unanimously scored as having APHE, 27.7% showed both rim and nonrim subtypes on mHAP. Inter-reader agreement for APHE subtype ranged from 0.49 (95% CI: 0.33, 0.64) to 0.57 (95% CI: 0.40, 0.74) between reading sessions. Observation size had a trend level effect on rim APHE agreement (p = 0.052).

Conclusion

Approximately 1/3 of observations demonstrated inconsistent APHE subtype during mHAP acquisition. Small lesions were particularly challenging. Further guidance on APHE subtype classification, especially when applied to mHAP, could be a focus of LI-RADS refinement.

Key Points

• In a cohort of patients at risk for HCC, 28% of the observations showed inconsistent arterial phase hyperenhancement (APHE) subtypes (rim and nonrim) on multi-arterial phase imaging according to the majority score of 5 independent readers.

• Inconsistent APHE subtypes may challenge reliable imaging diagnosis, i.e., LI-RADS categorization, of focal liver observations in patients at risk for HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

HCC:

Hepatocellular carcinoma

HIPAA:

Health Insurance Portability and Accountability Act

LI-RADS:

Liver Imaging Reporting and Data System

mHAP:

Multi-hepatic arterial phase

References

  1. Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750

    Article  Google Scholar 

  2. Available at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADS/CT-MRI-LI-RADS-v2018

  3. Ren AH, Zhao PF, Yang DW et al (2019) Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017. J Magn Reson Imaging 50:746–755

    Article  Google Scholar 

  4. Clarke SE, Saranathan M, Rettmann DW et al (2015) High resolution multi-arterial phase MRI improves lesion contrast in chronic liver disease. Clin Invest Med 31:E90–E99

    Article  Google Scholar 

  5. Qu J, Han S, Zhang H et al (2016) Improved detection of recurrent hepatocellular carcinomas in arterial phase with CAIPIRINHA-Dixon-TWIST-volumetric interpolated breath-hold examination. Invest Radiol 51:602–608

    Article  CAS  Google Scholar 

  6. Ikram NS, Yee J, Weinstein S et al (2017) Multiple arterial phase MRI of arterial hypervascular hepatic lesions: Improved arterial phase capture and lesion enhancement. Abdom Radiol (NY) 42:870–876

  7. Huang JS, Pan HB, Chou CP et al (2008) Optimizing scanning phases in detecting small [< 2 cm] hepatocellular carcinoma: Whole-liver dynamic study with multidetector row CT. J Comput Assist Tomogr 32:341–346

    Article  Google Scholar 

  8. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 1:159–174

    Article  Google Scholar 

  9. Ichikawa S, Motosugi U, Oishi N et al (2018) Ring-like enhancement of hepatocellular carcinoma in gadoxetic acid–enhanced multiphasic hepatic arterial phase imaging with differential subsampling with Cartesian ordering. Invest Radiol 53:191–199

    Article  CAS  Google Scholar 

  10. Ito K, Fujita T, Shimizu A et al (2004) Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: Differentiating between hypervascular hepatocellular carcinomas and pseudolesions. AJR Am J Roentgenol 183:699–705

  11. Kang JH, Choi SH, Lee JS et al (2020) Interreader agreement of Liver Imaging Reporting and Data System on MRI: A systematic review and meta-analysis. J Magn Reson Imaging 52:795–804

    Article  Google Scholar 

  12. Lim K, Kwon H, Cho J (2020) Inter-reader agreement and imaging-pathology correlation of the LI-RADS M on gadoxetic acid-enhanced magnetic resonance imaging: Efforts to improve diagnostic performance. Abdom Radiol (NY) 45:2430–2439

  13. Kim MY, Joo I, Kang HJ et al (2020) LI-RADS M [LR-M] criteria and reporting algorithm of v2018: Diagnostic values in the assessment of primary liver cancers on gadoxetic acid-enhanced MRI. Abdom Radiol (NY) 45:2440–2448

  14. Kim SS, Lee S, Choi JY et al (2020) Diagnostic performance of the LR-M criteria and spectrum of LI-RADS imaging features among primary hepatic carcinomas. Abdom Radiol (NY) 45:3743–3754

  15. Kim YY, Kim MJ, Kim EH et al (2019) Hepatocellular carcinoma versus other hepatic malignancy in cirrhosis: Performance of LI-RADS version 2018. Radiology 291:72–80

    Article  Google Scholar 

Download references

Funding

This study was partially funded by epd12088-GE:SirlinA-22 grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guilherme Moura Cunha.

Ethics declarations

Guarantor

All authors take public responsibility for the content of this work. The data is also available by request to Dr Guilherme Moura Cunha, MD, the scientific guarantor of this publication.

Conflict of interest

CBS has received research grants from Foundation of NIH, Bayer Pharmaceutics, GE Healthcare, Gilead Sciences Inc., Philips, and Siemens. He also has consulting agreements with Blade, Boehringer, and Epigenomics and consulting agreements under auspices of University of California with AMRA, BMS, Exact Sciences, GE Digital, and IBM-Watson.

KJF has received research grants from Foundation of NIH, Bayer Pharmaceutics, GE Healthcare, and Siemens. She has consulting agreements with Bayer Pharmaceutics and Epigenomics.

All other authors involved in this work have no conflicts of interest or industry support to disclose with regard to the current manuscript. This includes financial or personal relationships that inappropriately influence his or her actions within 3 years of the work beginning submitted.

Statistics and biometry

One of the authors (KH) has significant statistical expertise.

Informed consent

Written informed consent was waived by the Institutional Review Board.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• retrospective

• cross-sectional observational study

• performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cunha, G.M., Hasenstab, K.A., Delgado, T. et al. Multi-arterial phase MRI depicts inconsistent arterial phase hyperenhancement (APHE) subtypes in liver observations of patients at risk for hepatocellular carcinoma. Eur Radiol 31, 7594–7604 (2021). https://doi.org/10.1007/s00330-021-07924-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-021-07924-8

Keywords

Navigation